Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06661655Not ApplicableRecruiting

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Role: lead

NCT06387745Not ApplicableNot Yet Recruiting

Referral of Patients to Hepatology With Hepatoscope

Role: collaborator

NCT04782050Not ApplicableCompleted

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation

Role: lead

NCT05120557Not ApplicableUnknown

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Role: lead

All 4 trials loaded